NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

A publication is a publication. No one then 8-K’s a prediction of what the FDA might or might not do at some future date based thereon, or they shouldn’t. That’s not what 8-K’s are used to communicate. Anyone who knows absolutely anything about filings and has any experience with them knows you don’t predict a future regulatory result based upon an publication and certainly not based upon an unblinded one. They can maybe give some idea of next steps, but again, that’s not what 8-K’s are supposed to be used to communicate. Period.